Showing results (441-450 of 1,811) with videos related to

Sort By:
Pageof 182
Transplantation and Cellular Therapy|December 2, 2021
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor TransplantationArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Transplantation and Cellular Therapy|November 14, 2021
Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research StudyJun Zou, Tao Wang, Meilun He, et al.
Transplantation and Cellular Therapy|November 14, 2021
Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial OutcomesPaul V O'Donnell, Claudio G Brunstein, Ephraim J Fuchs, et al.
Transplantation and Cellular Therapy|November 14, 2021
Iron Chelation With Deferasirox Increases Busulfan AUC During Conditioning Chemotherapy Prior to Allogeneic Stem Cell TransplantationSonja Essmann, Adrin Dadkhah, Dietlinde Janson, et al.
Transplantation and Cellular Therapy|December 7, 2021
Decision Analysis for Unrelated Bone Marrow Transplantation or Immediate Cord Blood Transplantation for Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete RemissionShinichi Kako, Fumihiko Hayakawa, Koichi Miyamura, et al.
Transplantation and Cellular Therapy|December 26, 2021
Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome StructureHaneen Daoud-Asfour, Israel Henig, Itai Ghersin, et al.
Transplantation and Cellular Therapy|December 26, 2021
American Society for Transplantation and Cellular Therapy Guidelines for Fellowship Training in Hematopoietic Cell Transplantation and Immune Effector Cell TherapyTania Jain, Tristan Knight, Maritza C Alencar, et al.
Transplantation and Cellular Therapy|February 19, 2022
Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic TransplantationAmeet Patel, Karina Wilkerson, Heidi Chen, et al.
Transplantation and Cellular Therapy|February 9, 2022
Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center ExperienceMaria Queralt Salas, Ivan Pasic, Mats Remberger, et al.
Transplantation and Cellular Therapy|February 9, 2022
Multiple Breath Washout Testing to Identify Pulmonary Chronic Graft Versus Host Disease in Children After Hematopoietic Stem Cell TransplantationJonathan H Rayment, Rodrigo A Sandoval, Juliana P Roden, et al.
Pageof 182